Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
• Profil Institute for Clinical Research (San Diego, CA) has appointed of John Amatruda, MD, a Pharmaceutical Research Executive, and Jerrold Olefsky, MD, Professor of Medicine at the University of California, San Diego, to its Board of Directors.
John Amatruda, MD
• With more than 20 years of experience in the pharma industry, George Köllner has joined contract research provider Syntagon's (Södertälje, Sweden) quality assurance and regulatory team where he will oversee GMP projects.
• Chiltern International (London, UK) announced that Marcelo Piccirillo, MD, and Carlo Lanza, MD, have joined the company, bringing their expertise in the areas of gastroenterology, oncology, and pediatrics to serve clients' needs.
Carlo Lanza, MD
• Clinipace Worldwide (Zurich, Switzerland) has appointed Jürgen Frisch, MD, to Chief Medical Officer of European Operations.
Jürgen Frisch, MD
• Clinical Site Services (Glen Burnie, MD) has made several new additions including Peter Zalewski as Director of Visual Communications, Nicole Giles as Site Support Specialist, and Kristina Astle as Marketing Associate.
Peter Zalewski
• RadSite (Houston, TX) has named three new members to its advisory board including Anthony Defrance, MD, Clinical Associate Professor, Stanford University, Director of Cardiology, HealthHelp, Medical Director for the CVCTA Education Center, and Director of Cardiovascular Imaging at Nevada Imaging Centers; David Levin, MD, former Chair of Radiology at Thomas Jefferson University Hospital, faculty appointments and leadership roles at the New York Hospital-Cornell Medical Center, Downstate Medical Center, Harvard Medical School, and Brigham and Women's Hospital; and Jon Shanser, MD, Diagnostic Radiologist at Reno Diagnostic Center; former Chairman of the ACR Coding & Nomenclature Committee and its Regulatory Compliance Task Force, former President of the CRS, and current Executive Committee Member.
• CTI Clinical Trial and Consulting Services (Cincinnati, OH) has made several new hires and promotions including Therese Swaisgood as a Clinical Coding Specialist, and Katelyn Westerkamp and Michel Conner both as Research Associates. Recently promoted are Stephanie Makepeace to Senior Project Manager and Medical Writer, Mike Montani to Senior Project Manager, and Robert McRae to Study Coordinator.
• Premier Research Group (Philadelphia, PA) has hired Sean Russell to the position of Vice President, Marketing, where he will have global responsibility for leading and developing global marketing.
• Following a career with increasing levels of responsibility in finance for several successful, global public companies, Stuart Grant has been appointed Patheon's (Toronto, CA) Executive Vice President, Chief Financial Officer.
• Y-Prime Technologies (Malvern, PA), a provider of clinical trial management consulting services and software solutions, has named Dave Espenshade Vice President of Sales and Marketing.
•Bringing with him over 28 years of leadership experience in oncology R&D, Preclinical Oncology Services (Nottingham, UK) has appointed Martin Page, PhD, as Scientific Consultant.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.